{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:22:21Z","timestamp":1777861341303,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015285","name":"Hebei Province Medical Science Research Key Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clineuro.2026.109385","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:05:45Z","timestamp":1773126345000},"page":"109385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A multidimensional study of antiplatelet therapy and CYP2C19 genetic testing in patients with ischemic stroke and transient ischemic attack"],"prefix":"10.1016","volume":"266","author":[{"given":"Zhiye","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingrui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0131-666X","authenticated-orcid":false,"given":"Shuojun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clineuro.2026.109385_bib1","first-page":"1071","article-title":"Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack 2022 [in Chinese]","volume":"55","author":"Society","year":"2022","journal-title":"Chin. J. Neurol."},{"key":"10.1016\/j.clineuro.2026.109385_bib2","first-page":"973","article-title":"Personalized approaches to antiplatelet treatment for cardiovascular diseases: an umbrella review","volume":"16","author":"Oliva","year":"2023","journal-title":"Pharm. Pers. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109385_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109385_bib4","first-page":"529","article-title":"Clopidogrel hyporesponsiveness and the FDA boxed warning: detection and management of patients with genetic polymorphisms","volume":"68","author":"Perry","year":"2011","journal-title":"Am. J. HealthSyst. Pharm. AJHP Off. J. Am. Soc. HealthSyst. Pharm."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109385_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/clpt.2013.105","article-title":"Clinical pharmacogenetics implementation consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update","volume":"94","author":"Scott","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clineuro.2026.109385_bib6","first-page":"8645","article-title":"Adherence to Guidelines on Nutritional Support by Medical Residents in an Intensive Care Unit in China: a prospective observational study","volume":"25","author":"Yang","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109385_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s10897-012-9504-z","article-title":"Attitudes and practices among internists concerning genetic testing","volume":"22","author":"Klitzman","year":"2013","journal-title":"J. Genet. Couns."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109385_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11173-w","article-title":"Antibiotic prescribing practices, perceived constraints, and views on antimicrobial resistance among general and orthopedic surgeons in central India","volume":"15","author":"Skender","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109385_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043557","article-title":"Influencing factors and their relationships of risk perception and decision-making behaviour of polypharmacy in patients with chronic diseases: a qualitative descriptive study","volume":"11","author":"Liu","year":"2021","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.clineuro.2026.109385_bib10","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1016\/j.asjsur.2024.07.199","article-title":"Summary of the best evidence for preventing the occurrence of subcutaneous emphysema in laparoscopic surgery","volume":"47","author":"Zhao","year":"2024","journal-title":"Asian J. Surg."},{"issue":"18","key":"10.1016\/j.clineuro.2026.109385_bib11","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"Zitzelsberger L. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ","volume":"182","author":"Brouwers","year":"2010","journal-title":"Can. Med. Assoc. J. = J. De. l\u2032Assoc. Med. Can."},{"key":"10.1016\/j.clineuro.2026.109385_bib12","author":"Collaboration","year":"2010","journal-title":"Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109385_bib13","first-page":"91","article-title":"Evaluation of clinical practice guidelines for osteoporosis and comprehensive value study of drugs [in Chinese","volume":"40","author":"Wang","year":"2020","journal-title":"Chin. J. Hosp. Pharm."},{"issue":"21","key":"10.1016\/j.clineuro.2026.109385_bib14","first-page":"1919","article-title":"Quality of critical care clinical practice guidelines involving pharmacotherapy recommendations","volume":"79","author":"Edwards","year":"2022","journal-title":"Am. J. HealthSyst. Pharm. AJHP Off. J. Am. Soc. HealthSyst. Pharm."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109385_bib15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/STROKEAHA.116.015434","article-title":"Using the National institutes of health stroke scale: a cautionary tale","volume":"48","author":"Lyden","year":"2017","journal-title":"Stroke"},{"issue":"9558","key":"10.1016\/j.clineuro.2026.109385_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","article-title":"Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack","volume":"369","author":"Johnston","year":"2007","journal-title":"Lancet (Lond. Engl. )"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109385_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12875-024-02405-5","article-title":"Self-initiated lifestyle changes during a fasting-mimicking diet programme in patients with type 2 diabetes: a mixed-methods study","volume":"25","author":"van den Burg","year":"2024","journal-title":"BMC Prim. care"},{"key":"10.1016\/j.clineuro.2026.109385_bib18","first-page":"42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Impl. Sci. IS"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109385_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implementation science IS"},{"issue":"4","key":"10.1016\/j.clineuro.2026.109385_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/bjhp.12598","article-title":"Examining drivers of self-harm guideline implementation by general practitioners: a qualitative analysis using the theoretical domains framework","volume":"27","author":"Leather","year":"2022","journal-title":"Br. J. Health Psychol."},{"key":"10.1016\/j.clineuro.2026.109385_bib21","article-title":"Factors influencing the utilization of Traditional Chinese Medicine in cancer treatment: a qualitative meta-synthesis of patient and healthcare professional perspectives","volume":"12","author":"Xu","year":"2025","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109385_bib22","article-title":"Organizational capacity for patient and family engagement in hospital planning and improvement: interviews with patient\/family advisors, managers and clinicians","volume":"33","author":"Anderson","year":"2021","journal-title":"Int. J. Qual. Health Care J. Int. Soc. Qual. Health Care"},{"issue":"8","key":"10.1016\/j.clineuro.2026.109385_bib23","first-page":"910","article-title":"Chinese Clinical Management Guidelines for Cerebrovascular Diseases (2nd Edition) (Excerpt)-Chapter 4 Recommendations for Clinical Management of Ischemic Cerebrovascular Diseases [in Chinese]","volume":"18","author":"Liu","year":"2023","journal-title":"Chin. J. Stroke"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109385_bib24","first-page":"523","article-title":"Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023 [in Chinese]","volume":"57","author":"Society","year":"2024","journal-title":"Chin. J. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109385_bib25","first-page":"382","article-title":"Guidelines for chronic disease management of elderly ischemic stroke [in Chinese","volume":"14","author":"Dong","year":"2022","journal-title":"Chin. J. Integr. Trad. West Med Res"},{"issue":"5","key":"10.1016\/j.clineuro.2026.109385_bib26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/cpt.2526","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update","volume":"112","author":"Lee","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.clineuro.2026.109385_bib27","first-page":"1378","article-title":"Meta-analysis of CYP2C19 genotype-guided personalized clopidogrel therapy for efficacy and safety in ischemic stroke [in Chinese","volume":"53","author":"Yang","year":"2024","journal-title":"Chongqing Med"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109385_bib28","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1161\/CIR.0000000000001257","article-title":"CYP2C19 genetic testing for oral P2Y12 inhibitor therapy: a scientific statement from the american heart association","volume":"150","author":"Pereira","year":"2024","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.clineuro.2026.109385_bib29","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA","volume":"385","author":"Wang","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109385_bib30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcin.2020.01.226","article-title":"Derivation, validation, and prognostic utility of a prediction rule for nonresponse to clopidogrel: the ABCD-GENE score","volume":"13","author":"Angiolillo","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.clineuro.2026.109385_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.670155","article-title":"Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease","volume":"12","author":"Nusca","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109385_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ehjcvp\/pvae040","article-title":"CYP2C19 genetic testing for Mavacamten and ischaemic stroke treatment: What does the result mean for cardiovascular prescribers in the UK and Europe?","volume":"10","author":"Magavern","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109385_bib33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/17474930221111898","article-title":"Cost-effectiveness of testing for CYP2C19 loss-of-function carriers following transient ischemic attack\/minor stroke: a Canadian perspective","volume":"18","author":"Micieli","year":"2023","journal-title":"Int. J. Stroke Off. J. Int. Stroke Soc."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109385_bib34","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1038\/s41598-021-86824-9","article-title":"Cost-effectiveness of CYP2C19 genotyping to guide antiplatelet therapy for acute minor stroke and high-risk transient ischemic attack","volume":"11","author":"Cai","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.clineuro.2026.109385_bib35","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s40261-020-00970-y","article-title":"Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations","volume":"40","author":"Narasimhalu","year":"2020","journal-title":"Clin. Drug Investig."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109385_bib36","first-page":"313","article-title":"Critical reflections on the development boom of clinical personalized medication research in China [in Chinese]","volume":"41","author":"Chen","year":"2021","journal-title":"J. Nanjing Med Univ. (Nat. Sci.)"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:46:22Z","timestamp":1777520782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"alternative-id":["S0303846726000776"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109385","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multidimensional study of antiplatelet therapy and CYP2C19 genetic testing in patients with ischemic stroke and transient ischemic attack","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109385"}}